Skip Navigation
Skip to contents

IMKASID 2024

Region-Specific Forum 08:30~10:00, Room A

  • Choosing and Positioning Biologic Therapy for Biologic-Naïve IBD Patients Julajak Limsrivilai Mahidol University
    Thailand
    CV
  • Implementing Quality Measures for IBD Patients Wong Zhiqin The National University of Malaysia
    Malaysia
    CV
  • Infectious Mimics of IBD Dao Viet Hang Hanoi Medical University
    Vietnam
    CV
  • The Many Faces of Cytomegalovirus in IBD Rabbinu Rangga Pribadi Cipto Mangunkusumo National General Hospital
    Indonesia
    CV

KASID-MISGKAI Joint Symposium 08:30~10:00, Room B

  • Macrophages in Intestinal Inflammation and Resolution Seung Hyeok Seok Seoul National University
    Korea
    CV
  • Regulation of Gut-Homing T Cells in Inflammatory Bowel Disease Seong-Joon Koh Seoul National University
    Korea
    CV
  • Current Strategies and Potential Prospects of Nanomedicine-mediated Therapy Yonghyun Lee Ewha Womans University
    Korea
    CV
  • Dietary Fiber and Inflammatory Bowel Disease Sung Wook Hwang University of Ulsan
    Korea
    CV

Symposium 1 10:20~11:50, Room A The Cutting-edge Issues in IBD

  • Can We Predict the Development of IBD using a Multi-Omics Approach? Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
    USA
    CV
  • The Long Journey to Prevent and Overcome the Development of Fibrosis and Stricture in IBD Florian Rieder Cleveland Clinic
    USA
    CV
  • Proper Positioning of Biologics and Small Molecules in Patients with IBD Silvio Danese University Vita-Salute San Raffaele
    Italy
    CV
  • Exit Strategies: Can We Stop Medications in Patients with IBD? Kang-Moon Lee The Catholic University of Korea
    Korea
    CV

Symposium 2 10:20~11:50, Room B Hot Topics in Epidemiology, Screening, and Prevention of Colorectal Cancer

  • Time Trends of Colorectal Cancer Epidemiology: How is It Changing? NaNa Keum Dongguk University
    Korea
    CV
  • Colorectal Cancer Screening: Tests, Strategies, and Perspectives Hyun-Soo Kim Yonsei University
    Korea
    CV
  • Prevention of Colorectal Cancer: Foods, Exercise, and Lifestyle Modifications - Do They Really Work?  Aesun Shin Seoul National University
    Korea
    CV
  • Chemoprevention of Colorectal Cancer: Evidence from Real-World Clinical Data in Sweden Jianguang Ji Lund University
    Sweden
    CV
  • KASID-GEST Joint Symposium 10:20~11:50, Room C Microbiome in Colorectal Neoplasia

    • Who is the Foe?: Gut Microbiome and Colorectal Neoplasm Soo-Young Na The Catholic University of Korea
      Korea
      CV
    • Microbiota-Associated Mechanisms in Colorectal Carcinogenesis Chun-Ying Wu National Yang Ming Chiao Tung University
      Taiwan
      CV
    • Are We Ready for Microbiota-Based Screening of Colorectal Cancer? Hong Sub Lee Inje University
      Korea
      CV
    • Our Old Friend, Probiotics for Prevention of Colorectal Neoplasia Chi-Yang Chang Fu Jen Catholic University Hospital
      Taiwan
      CV
    • Luncheon Symposium 11:50~12:40, Room A

      • Disease Clearance as a Treatment Goal in Ulcerative Colitis:
        From Concept to Clinical Practice
        Silvio Danese University Vita-Salute San Raffaele
        Italy
        CV
      • Targeting Progression
        of Crohn’s Disease to Improve
        Patient Outcomes
        Young-Ho Kim Sungkyunkwan University
        Korea
        CV
      • Luncheon Symposium 11:50~12:40, Room B

        • Optimal Dose of Mesalazine in Ulcerative Colitis:
          Focused on High Dose Mesalazine
          Johan Burisch University of Copenhagen
          Denmark
          CV
        • An Innovative Colonic Targeting:
          OPTICORE Coating Technology
          Jae Hee Cheon Yonsei University
          Korea
          CV
        • Luncheon Symposium 12:40~13:30, Room A

          • Up-to-Date Evidence and Experience on
            CD: Including the First Head-to-Head
            Results and Asian Experience
            Takayuki Matsumoto Iwate Medical University
            Japan
            CV
          • Recent Clinical Data and Guidelines
            to Support Evidence-Based Decisions in UC
            Byong Duk Ye University of Ulsan
            Korea
            CV
          • Luncheon Symposium 12:40~13:30, Room B

            • Safety and Efficacy of the 1st Adalimumab Biosimilar in IBD Treatment based on
              Real World Evidence
              Milan Lukas Charles University
              Czech
              CV
            • IBD Treatment Journey with the 1st
              Adalimumab Biosimilar
              Dong Il Park Sungkyunkwan University
              Korea
              CV
            • Symposium 3 14:10~15:40, Room A Recent Advances in High Quality Colonoscopy & Surveillance of Colorectal Cancer

              • High-Quality Screening Colonoscopy: A Matter of Time, Technique, or Technology? David G. Hewett The University of Queensland
                Australia
                CV
              • Distinguishing between Different Bowel Preparation Agents:
                How to Make the Right Choice?
                Jae Myung Cha Kyung Hee University
                Korea
                CV
              • Sessile Serrated Lesions: How to Detect, Differentiate, and Resect Hyun Jung Lee Seoul National University
                Korea
                CV
              • Update on Post-Polypectomy Surveillance Guidelines: What has Changed? Min Seob Kwak Kyung Hee University
                Korea
                CV

              Symposium 4 14:10~15:40, Room B Up-to-date Research in Gut Microbiome

              • Understanding of Gastrointestinal Diseases Using Organoid Technology Toshiro Sato Keio University
                Japan
                CV
              • Therapeutic Microbiome in IBD Animal Model: A Recent Update GwangPyo Ko Seoul National University
                Korea
                CV
              • COVID-19 and Human Gut Microbiome: What Do We Know? Siew C. Ng The Chinese University of Hong Kong
                China
                CV
              • Gut Microbiome as a Novel Biomarker in IBD Dong Il Park Sungkyunkwan University
                Korea
                CV

              IMOTICON 14:10~15:40, Room C International Multi-society Online Case Conference for Intestinal Diseases

              • Post-Coletomy GI Bleeding in Crohn's Disease Dao Viet Hang Hanoi Medical University
                Vietnam
                CV
              • An Unusual Case of Small Bowel Strictures Sneha John Gold Coast University Hospital
                Australia
                CV
              • Hematochezia after Treatment of Ankylosing Spondylitis with Ixekizumab Seulji Kim Seoul National University
                Korea
                CV
              • Recurrent Bloody Stools due to Small Bowel Bleeding Imelda Loho  Dharmais National Cancer Center
                Indonesia
                CV

              Symposium 5 16:00~17:30, Room A Challenging Cases in IBD

              • A 29-year-old Man Presented with Bloating and Borborygmus Han Hee Lee The Catholic University of Korea
                Korea
                CV
              • A 75-year-old Man Presented
                with Abdominal Pain and Hematochezia
                Soo-Kyung Park Sungkyunkwan University
                Korea
                CV
              • A 22-year-old Man Presented
                with Recurrent Perianal Abscess
                Hyuk Yoon Seoul National University
                Korea
                CV

              Symposium 6 16:00~17:30, Room B Deep Dive into Small Bowel Diseases

              • Drug-induced Small Bowel Injury: A Time to Take Care Seong-Eun Kim Ewha Womans University
                Korea
                CV
              • CEAS and CMUSE: Who are you? Takayuki Matsumoto Iwate Medical University
                Japan
                CV
              • Role of Endoscopy for Small Bowel Tumors Jinsu Kim The Catholic University of Korea
                Korea
                CV
              • Advances in Therapeutic Endoscopy for Small Bowel Disease Chia-Hung Tu National Taiwan University
                Taiwan
                CV
Diamond
  • abbvie
  • CELLTRION PHARM
  • Jassen
  • SAMSUNG BIOEPIS
  • Takeda
Platinum
  • Bristrol Myers Squibb
  • DEAWOONG
  • FERRING PHARMACEUTICALS
Gold
  • Eisasi Korea Inc.
  • Pfizer
Bronze
  • GSK
  • Pharmbio Korea Inc.
  • TAEJOON

Go Top

Korean Association for the Study of Intestinal Diseases
31, Seolleung-ro 86 Gil, Gangnam-Gu, Seoul, 06193, Korea
IMKASID 2024 Secretariat [People-x, Inc.]
  • 1F, Haeoreum B/D, 16, Yeoksam-ro 17-gil, Gangnam-gu, Seoul, 06246, Korea
    [All Inquiries] info@imkasid.kr
    [Scientific Program/Abstract] +82-2-566-5951
    [Registration] +82-70-4895-6139
    [Sponsorship] +82-70-4895-6110

Copyright ⓒ Korean Association for the Study of Intestinal Diseases All rights reserved